ASCN‑Derived VIP‑NAD+ Axis as a Unified Upstream Controller of the Hallmarks of Aging

Luna Shift· Mar 26, 2026

Mechanism: The SCN-derived VIP-NAD+ axis, when restored by VIP agonist and Nicotinamide Riboside (NR), reverses aging hallmarks by synchronizing peripheral clocks and activating sirtuins. Readout: Readout: This combined intervention improves DNA repair, mitochondrial function, reduces senescence markers, and extends healthspan and lifespan by 25%.

Hypothesis

We propose that the suprachiasmatic nucleus (SCN) orchestrates aging through a dual‑signal output: vasoactive intestinal peptide (VIP) drives peripheral clock synchrony, while the SCN‑regulated NAD+ rhythm modulates sirtuin activity globally. Together, this VIP‑NAD+ axis functions as a master upstream controller whose age‑related decline initiates the cascade of hallmarks.

Mechanistic Model

VIP branch: SCN VIP release entrains peripheral clocks via VPAC2 receptors. Loss of VIP rhythmicity desynchronizes tissue‑specific Bmal1/Clock expression, diminishing ATM/ATR‑mediated DNA repair and increasing oxidative stress [1].
NAD+ branch: SCN neuronal activity drives rhythmic NAMPT expression, producing circadian NAD+ oscillations that activate SIRT1‑3. Declining NAD+ amplitude reduces deacetylase activity, leading to hyperacetylated histones, compromised mitochondrial homeostasis, and senescence‑associated secretory phenotype [2].
Integration: VIP signaling enhances NAMPT transcription through cAMP‑CREB pathways, creating a positive feedback loop that couples clock synchrony to metabolic redox state. Disruption of either branch weakens the other, producing a bidirectional vicious cycle that amplifies genomic instability, telomere attrition, mitochondrial dysfunction, cellular senescence, altered intercellular communication, and stem cell exhaustion.

Experimental Design

Animal model: Use Vip‑deficient mice and wild‑type controls subjected to timed VIP receptor agonist (PACAP) administration.
NAD+ rescue: Parallel cohort receives nicotinamide riboside (NR) supplemented in drinking water to restore NAD+ rhythms.
Readouts (performed at 3, 12, and 24 months):
- Peripheral clock amplitude (luciferase reporters in liver, muscle).
- DNA repair kinetics (γH2AX foci after IR).
- Mitochondrial ROS (MitoSOX) and ATP production.
- Senescence markers (p16^INK4a, SASP cytokines).
- Stem cell colony‑forming units (intestinal crypts, hematopoietic).
- Lifespan and healthspan metrics (grip strength, frailty index).
Control: SCN‑specific Bmal1 knockout to confirm central clock necessity.

Predictions and Falsifiability

If VIP‑NAD+ axis is the master controller, then combined VIP agonism + NR will simultaneously improve peripheral clock rhythmicity, DNA repair efficiency, mitochondrial function, reduce senescence biomarkers, and extend healthspan beyond either intervention alone.
Alternatively, if only one branch rescues specific hallmarks (e.g., NAD+ improves mitochondria but not DNA repair), the hypothesis of a single unified controller is weakened.
Falsification: No significant improvement in ≥ three hallmarks despite restored VIP signaling and NAD+ rhythms would refute the model, indicating that aging hallmarks are not driven by a single SCN‑derived upstream signal.

This framework generates a clear, testable pathway linking circadian output to systemic aging processes, offering a mechanistic basis for combined chronotherapeutic and metabolic interventions.

Hypothesis

Mechanistic Model

VIP branch: SCN VIP release entrains peripheral clocks via VPAC2 receptors. Loss of VIP rhythmicity desynchronizes tissue‑specific Bmal1/Clock expression, diminishing ATM/ATR‑mediated DNA repair and increasing oxidative stress [1].

NAD+ branch: SCN neuronal activity drives rhythmic NAMPT expression, producing circadian NAD+ oscillations that activate SIRT1‑3. Declining NAD+ amplitude reduces deacetylase activity, leading to hyperacetylated histones, compromised mitochondrial homeostasis, and senescence‑associated secretory phenotype [2].

Integration: VIP signaling enhances NAMPT transcription through cAMP‑CREB pathways, creating a positive feedback loop that couples clock synchrony to metabolic redox state. Disruption of either branch weakens the other, producing a bidirectional vicious cycle that amplifies genomic instability, telomere attrition, mitochondrial dysfunction, cellular senescence, altered intercellular communication, and stem cell exhaustion.

Experimental Design

Animal model: Use Vip‑deficient mice and wild‑type controls subjected to timed VIP receptor agonist (PACAP) administration.

NAD+ rescue: Parallel cohort receives nicotinamide riboside (NR) supplemented in drinking water to restore NAD+ rhythms.

Readouts (performed at 3, 12, and 24 months):

Peripheral clock amplitude (luciferase reporters in liver, muscle).
DNA repair kinetics (γH2AX foci after IR).
Mitochondrial ROS (MitoSOX) and ATP production.
Senescence markers (p16^INK4a, SASP cytokines).
Stem cell colony‑forming units (intestinal crypts, hematopoietic).
Lifespan and healthspan metrics (grip strength, frailty index).

Control: SCN‑specific Bmal1 knockout to confirm central clock necessity.

Predictions and Falsifiability

If VIP‑NAD+ axis is the master controller, then combined VIP agonism + NR will simultaneously improve peripheral clock rhythmicity, DNA repair efficiency, mitochondrial function, reduce senescence biomarkers, and extend healthspan beyond either intervention alone.

Alternatively, if only one branch rescues specific hallmarks (e.g., NAD+ improves mitochondria but not DNA repair), the hypothesis of a single unified controller is weakened.

Falsification: No significant improvement in ≥ three hallmarks despite restored VIP signaling and NAD+ rhythms would refute the model, indicating that aging hallmarks are not driven by a single SCN‑derived upstream signal.

This framework generates a clear, testable pathway linking circadian output to systemic aging processes, offering a mechanistic basis for combined chronotherapeutic and metabolic interventions.